FR1865M - Nouvel éthyl-ammonium-hydroxyde, utilisable en thérapeutique, notamment comme médicament spasmolytique. - Google Patents

Nouvel éthyl-ammonium-hydroxyde, utilisable en thérapeutique, notamment comme médicament spasmolytique.

Info

Publication number
FR1865M
FR1865M FR892302A FR892302A FR1865M FR 1865 M FR1865 M FR 1865M FR 892302 A FR892302 A FR 892302A FR 892302 A FR892302 A FR 892302A FR 1865 M FR1865 M FR 1865M
Authority
FR
France
Prior art keywords
usable
therapy
ammonium hydroxide
ethyl ammonium
new ethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR892302A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
BASF Schweiz AG
Original Assignee
Ciba Geigy AG
Ciba AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR885183A external-priority patent/FR1331931A/fr
Application filed by Ciba Geigy AG, Ciba AG filed Critical Ciba Geigy AG
Priority to FR892302A priority Critical patent/FR1865M/fr
Application granted granted Critical
Publication of FR1865M publication Critical patent/FR1865M/fr
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
FR892302A 1961-01-19 1962-03-27 Nouvel éthyl-ammonium-hydroxyde, utilisable en thérapeutique, notamment comme médicament spasmolytique. Active FR1865M (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR892302A FR1865M (fr) 1961-01-19 1962-03-27 Nouvel éthyl-ammonium-hydroxyde, utilisable en thérapeutique, notamment comme médicament spasmolytique.

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US8361861A 1961-01-19 1961-01-19
US14482061A 1961-10-13 1961-10-13
FR885183A FR1331931A (fr) 1962-01-18 1962-01-18 Procédé de préparation de composés pyridylméthylindényliques
FR892302A FR1865M (fr) 1961-01-19 1962-03-27 Nouvel éthyl-ammonium-hydroxyde, utilisable en thérapeutique, notamment comme médicament spasmolytique.

Publications (1)

Publication Number Publication Date
FR1865M true FR1865M (fr) 1963-06-17

Family

ID=87571580

Family Applications (1)

Application Number Title Priority Date Filing Date
FR892302A Active FR1865M (fr) 1961-01-19 1962-03-27 Nouvel éthyl-ammonium-hydroxyde, utilisable en thérapeutique, notamment comme médicament spasmolytique.

Country Status (1)

Country Link
FR (1) FR1865M (fr)

Similar Documents

Publication Publication Date Title
FR3692M (fr) Nouveau aminoacide utilisable en thérapeutique, notamment comme spasmolytique musculaire et hypnotique.
FR3380M (fr) Nouvelles préparations anthelmintiques, utilisables en thérapeutique.
FR3734M (fr) Nouvelle pipérazine utilisable en thérapeutique, notamment comme agent hypotenseur.
FR2428M (fr) Antispasmodique.
FR1865M (fr) Nouvel éthyl-ammonium-hydroxyde, utilisable en thérapeutique, notamment comme médicament spasmolytique.
FR2065M (fr) Médicament a action analgésique a base de phényl-alkylamine.
FR2806M (fr) Sulfamylurées n,n-disubstituées.
FR2258M (fr) Médicament destiné, en particulier, a combattre l'insomnie.
FR2691M (fr) Nouveaux a-nor-b-homo-stéroides utilisables en thérapeutique, notamment comme gestagenes.
FR3782M (fr) Nouvelle isoquinoléine utilisable en thérapeutique, notamment comme béchique.
FR1453M (fr) Médicament analgéique, antithermique, antirhumatismal.
FR2407M (fr) Nouvelle cétone basique utilisable en thérapeutique, notamment comme stimulant.
FR3416M (fr) Nouveau aminoacide utilisable en thérapeutique, notamment comme spasmolytique musculaire et hypnotique.
FR2999M (fr) Nouvelle guanidine utilisable en thérapeutique, notamment comme hypoglycémiant.
BE616478A (fr) Nouveau composé stéroïde utilisable, notamment, comme médicament
FR3735M (fr) Acétylglutamate de pyridoxine, nouveau médicament utilisable notamment comme stimulant du systeme nerveux.
FR3729M (fr) 1-bromo-1-chloro-2,2-difluoropropane a titre de médicament nouveau.
IE23468L (en) After-treatment of polymer sheets, etc.
FR1029M (fr) Nouveau 17α-isobutyl-androstane-3β,17β-diol utilisable en thérapeutique.
FR1013M (fr) Médicament analgésique, antithermique et antirhumatismal.
CA580522A (fr) ACIDE .alpha.,.alpha.-DICHLOROISOVALERIQUE ET SES SELS
FR349M (fr) Nouvelle 1,3-dihydroxy-2-nitro-tricos-4-yne utilisable en thérapeutique.
FR2350M (fr) Nouvel indane utilisable en thérapeutique, notamment comme fongicide.
FR3137M (fr) Nouvel δ<4>-7α, 17α-diméthyl-17β-hydroxy-oestrene utilisable en thérapie.
CH362391A (fr) Bordatrice di lastre metalliche per fondi piani o bombati di serbatoi, caldaie, contenitori, ecc.